• We offer tailored partnerships to support and transform drug discovery.

    Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

  • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

    As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

  • Our OrganoReady program is made for you when you need optimized assays for investigational toxicology.

    We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon
EN

An Immunocompetent Kidney-on-a-Chip Model for Studying Renal Inflammation & Immune-Mediated Injury

Kidney inflammation plays a central role in many renal diseases, yet traditional in vitro models fall short in capturing the immune complexity and mechanistic insight needed to guide effective therapy development. Our immunocompetent kidney-on-a-chip model addresses this gap by integrating epithelial, endothelial, and immune cell co-culture in a high-throughput microfluidic platform.

Designed to mimic the human proximal tubule, this tri-culture system enables detailed investigation of immune-mediated injury, monocyte migration, and therapeutic modulation. The model also supports donor-specific response profiling, advancing personalized approaches to kidney disease research.

Key Features of the Model

  • 3D tri-culture of RPTEC, HUVECs, and human primary monocytes
  • Inducible inflammation via complement-activated serum (CAS)
  • Quantifiable readouts: ICAM-1 expression, IL-6 release, cell migration
  • High-throughput compatible using the OrganoPlate® platform
  • Test compound efficacy in modulating renal inflammation and immune cell behavior

 

Download the Poster

 

Cookies

May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy
Accept all
Accept selected
Decline all